X T L Biopharmaceuticals reported $5.1M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 5M 2M Sep/2025
Bioline Rx USD 56M 45M Jun/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
X T L Biopharmaceuticals USD 22M 8M Dec/2024